United Therapeutics Corporation
UTHR
$515.46
-$12.45-2.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.59% | -14.68% | 20.91% | 9.58% | 11.29% |
| Total Depreciation and Amortization | 14.69% | 14.14% | 15.74% | 14.66% | 12.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.59% | 272.33% | 359.70% | 8.33% | 45.02% |
| Change in Net Operating Assets | 38.87% | -84.10% | -340.40% | 1,150.00% | -86.58% |
| Cash from Operations | 63.59% | 0.46% | 1.47% | 49.02% | -17.44% |
| Capital Expenditure | -73.63% | -34.58% | -99.42% | -175.16% | -37.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 182.25% | 1,040.42% | -49.86% | 1,015.10% | -581.09% |
| Cash from Investing | 129.18% | 551.55% | -84.74% | 222.63% | -274.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | -300.00% |
| Issuance of Common Stock | 597.79% | 243.72% | 286.72% | 22.59% | -65.26% |
| Repurchase of Common Stock | 90.38% | -10,084.97% | -100.00% | -250,025.00% | -5,100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 70.43% | -- | -- | -- | -- |
| Cash from Financing | 161.63% | -1,482.52% | 231.73% | -1,391.42% | -313.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 270.63% | -236.85% | 51.43% | -227.65% | -394.43% |